Renal Tubular Acidosis
Non-anion gap metabolic acidosis (NAGMA) caused by defective renal acid handling. Type 1 (distal): cannot secrete H⁺. Type 2 (proximal): cannot reabsorb HCO₃⁻. Type 4: hypoaldosteronism → hyperkalemia.
🔍 Overview
RTA Classification
| Feature | Type 1 (Distal) | Type 2 (Proximal) | Type 4 (Hypoaldo) |
|---|---|---|---|
| Defect | Cannot secrete H⁺ in collecting duct | Cannot reabsorb HCO₃⁻ in proximal tubule | ↓ Aldosterone effect → ↓ H⁺/K⁺ secretion |
| Serum K⁺ | ↓ Hypokalemia | ↓ Hypokalemia | ↑ Hyperkalemia |
| Urine pH | > 5.5 (cannot acidify) | < 5.5 (can acidify once bicarb threshold exceeded) | < 5.5 |
| Serum HCO₃⁻ | Can be very low (< 10) | Usually 12–20 (self-limited) | Usually > 15 (mild) |
| Associations | Sjögren, SLE, nephrocalcinosis, kidney stones | Fanconi syndrome, multiple myeloma, carbonic anhydrase inhibitors | Diabetes (#1), ACEi/ARBs, K-sparing diuretics, adrenal insufficiency |
| Treatment | Oral NaHCO₃ 1–2 mEq/kg/day | Oral NaHCO₃ (high doses needed) + thiazide | Fludrocortisone (Florinef), low-K diet, loop diuretics |
Type 4 RTA is the most common RTA. Most commonly caused by diabetic nephropathy (hyporeninemic hypoaldosteronism). ACEi/ARBs and K-sparing diuretics also cause it.
Remember RTA Types by K⁺: Type 1 and 2 have LOW K⁺ (1+2 = numbers go DOWN like K). Type 4 has HIGH K⁺ (4 = FOUR = FOURget aldosterone = hyperK).
Fanconi Syndrome
Generalized proximal tubular dysfunction. Think of it as "everything leaks through the proximal tubule."
- Features: Type 2 RTA + glycosuria (normal blood glucose) + aminoaciduria + phosphaturia (hypophosphatemia/rickets) + uricosuria
- Causes: Multiple myeloma (light chains), tenofovir, cisplatin, Wilson disease, lead poisoning
- Key clue: Glucose in urine with NORMAL serum glucose = proximal tubular dysfunction, not diabetes
Approach to NAGMA: Algorithm
| Step | Question | Answer | Interpretation |
|---|---|---|---|
| 1 | Is the anion gap normal? | AG <=12 | Confirmed NAGMA. Proceed |
| 2 | Urine anion gap? | Negative (UCl > UNa + UK) | GI loss (diarrhea). Stop here |
| 3 | Urine anion gap? | Positive (UCl < UNa + UK) | RTA. Proceed to classify |
| 4 | Serum K+? | Hyperkalemia (>5.0) | Type 4 RTA. Check aldosterone/renin, medications |
| 5 | Serum K+? | Hypokalemia (<3.5) | Type 1 or Type 2. Check urine pH |
| 6 | Urine pH? | >5.5 | Type 1 (Distal). Check for stones, autoimmune |
| 7 | Urine pH? | <5.5 | Type 2 (Proximal). Check for Fanconi, myeloma |
Clinical pearl: Type 4 RTA is by far the most common RTA encountered in clinical practice, but Type 1 and Type 2 are more commonly tested on boards. In the real world, most "Type 4 RTA" is simply a diabetic patient on an ACEi with K+ of 5.8 and bicarb of 20. DeFronzo, Kidney Int 1980
🚨 Management
Treatment by Type
- Type 1 (Distal): Oral sodium bicarbonate or sodium citrate 1–2 mEq/kg/day. Potassium supplementation (KCl). Relatively easy to correct -low doses suffice.
- Type 2 (Proximal): Oral sodium bicarbonate -but requires HIGH doses (10–15 mEq/kg/day) because bicarb is wasted in urine. Add thiazide diuretic (induces mild volume contraction → increases proximal reabsorption). K⁺ supplementation often needed.
- Type 4: Treat hyperkalemia first. Fludrocortisone (Florinef) 0.1 mg daily if hypoaldosteronism. Low-potassium diet. Furosemide (Lasix) (increases K⁺ excretion). Discontinue offending drugs (ACEi, K-sparing diuretics, TMP-SMX).
Treatment Comparison Table
| Feature | Type 1 (Distal) | Type 2 (Proximal) | Type 4 (Hypoaldo) |
|---|---|---|---|
| Bicarb dose | Low (1-2 mEq/kg/day) | High (10-15 mEq/kg/day) | Usually not needed |
| Why? | Distal tubule cannot secrete H+, but proximal is intact so bicarb is retained | Proximal tubule wastes bicarb above lowered threshold, requiring massive replacement | Acidosis is mild (HCO3 usually >15) |
| K+ management | KCl supplementation (bicarb worsens hypoK) | KCl supplementation (bicarb worsens hypoK) | RESTRICT K+. Treat hyperK first |
| Unique therapy | Potassium citrate (prevents stones + corrects acidosis) | Add thiazide (volume contraction enhances proximal reabsorption) | Fludrocortisone 0.1 mg daily. Loop diuretics for K+ excretion |
| Stop offending drugs | Amphotericin B, lithium, toluene | Carbonic anhydrase inhibitors (acetazolamide), tenofovir, cisplatin | ACEi/ARBs, K-sparing diuretics, TMP-SMX, NSAIDs, heparin |
Important: When giving bicarb to Type 1 or Type 2 RTA, monitor K+ closely. Bicarb administration causes K+ to shift intracellularly (H+/K+ exchange), which can worsen hypokalemia. Always replete K+ before or simultaneously with bicarb. Laing & Unwin, Nat Rev Nephrol 2015
🧪 Workup
- ABG/VBG -non-anion gap metabolic acidosis (NAGMA)
- BMP -serum HCO₃⁻, K⁺, anion gap
- Urine pH -key differentiator (> 5.5 in Type 1)
- Urine anion gap -(Na⁺ + K⁺) - Cl⁻. Positive = RTA (renal cause). Negative = GI HCO₃⁻ loss (diarrhea).
- Serum aldosterone, renin (if Type 4 suspected)
- Urine electrolytes
Diagnostic Approach
- Step 1: Confirm NAGMA (normal anion gap metabolic acidosis)
- Step 2: Calculate urine anion gap → Positive = RTA, Negative = GI loss (diarrhea)
- Step 3: Check serum K⁺ → Hyperkalemia = Type 4, Hypokalemia = Type 1 or 2
- Step 4: Check urine pH → >5.5 = Type 1 (cannot acidify), <5.5 = Type 2
- Step 5: Look for associations → Stones/Sjögren = Type 1, Fanconi/myeloma = Type 2, DM/ACEi = Type 4
💊 Medications
| Drug | Dose | Type |
|---|---|---|
| Sodium Bicarbonate | 1–2 mEq/kg/day (Type 1); 10–15 mEq/kg/day (Type 2) | Types 1 & 2 |
| Potassium Citrate | 20–40 mEq BID-TID | Type 1 -corrects acidosis AND prevents stones |
| Fludrocortisone (Florinef) | 0.1 mg PO daily | Type 4 -mineralocorticoid replacement |
| Furosemide (Lasix) | 20–40 mg PO daily | Type 4 -enhances K⁺ excretion |
| Hydrochlorothiazide (Microzide) | 12.5–25 mg daily | Type 2 -volume contraction increases proximal HCO₃⁻ reabsorption |
📋 On Rounds
Pimp Questions
How does urine anion gap help differentiate causes of NAGMA?
Urine anion gap (UAG) = (UNa + UK) - UCl. In NAGMA from GI losses (diarrhea), the kidney compensates by excreting more NH₄⁺ (which carries Cl⁻) → UCl is high → UAG is negative (kidney is working). In RTA, the kidney CANNOT excrete acid properly → less NH₄⁺/Cl⁻ → UAG is positive (kidney is the problem). Mnemonic: "Negative is Normal" (the kidney is doing its job).
Why is Type 2 RTA harder to treat than Type 1?
In Type 2, the proximal tubule has a lowered threshold for HCO₃⁻ reabsorption. Any supplemental bicarb is filtered and immediately wasted in the urine (until serum bicarb falls below the lowered threshold). This means you need massive doses (10–15 mEq/kg/day), which also deliver a large sodium load → volume expansion → even more bicarb wasting. Adding a thiazide causes mild volume contraction, which increases proximal reabsorption efficiency.
What is the urine anion gap and how do you interpret it?
UAG = (UNa + UK) - UCl. It estimates urine NH4+ excretion. In normal renal response to acidosis, kidneys excrete lots of NH4+ (carried with Cl-), so UCl is high and UAG is negative. In RTA, kidneys cannot excrete acid properly, so NH4+/Cl- is low and UAG is positive. Mnemonic: "Negative is Normal" (kidneys doing their job, pointing to GI loss like diarrhea as the cause). Batlle et al, NEJM 1988
Why does Type 1 RTA cause kidney stones but Type 2 does not?
In Type 1 (distal) RTA, the persistently alkaline urine (pH >5.5) promotes precipitation of calcium phosphate stones (calcium phosphate is less soluble at high pH). Additionally, chronic acidosis causes bone buffering, releasing calcium into the blood and increasing urinary calcium excretion (hypercalciuria). The combination of alkaline urine + hypercalciuria = nephrocalcinosis and recurrent stones. Type 2 RTA has intermittently acidic urine (once serum bicarb falls below threshold), so stone risk is much lower. Caruana & Buckalew, Semin Nephrol 1988
How does the urine pH help differentiate Type 1 from Type 2 RTA?
Both Type 1 and Type 2 cause NAGMA with hypokalemia. The key differentiator is urine pH: Type 1: urine pH is ALWAYS >5.5 because the distal tubule fundamentally cannot secrete H+ (the defect). Type 2: urine pH is <5.5 once serum bicarb falls below the lowered reabsorption threshold (at that point, the filtered bicarb load is small enough for the proximal tubule to handle, and the intact distal tubule can acidify normally). So a patient with NAGMA + hypokalemia + urine pH <5.5 = Type 2. Urine pH >5.5 = Type 1.
What medications commonly cause Type 4 RTA?
Medications that impair the renin-angiotensin-aldosterone system or block aldosterone effect: (1) ACE inhibitors/ARBs - reduce angiotensin II and aldosterone production. (2) K-sparing diuretics - spironolactone, eplerenone (block aldosterone receptor), amiloride, triamterene (block ENaC). (3) TMP-SMX (Bactrim) - blocks ENaC like amiloride, causing hyperkalemia. (4) NSAIDs - reduce renin secretion via prostaglandin inhibition. (5) Heparin - directly inhibits aldosterone synthesis. (6) Calcineurin inhibitors (cyclosporine, tacrolimus). DeFronzo, Kidney Int 1980
A patient has NAGMA. How do you determine if it's RTA vs diarrhea?
Both RTA and diarrhea cause NAGMA. Use the urine anion gap (UAG): UAG = UNa + UK - UCl. Negative UAG = GI loss (diarrhea). The kidneys are working correctly, excreting NH4+ with Cl- to compensate. Positive UAG = RTA. The kidneys are the problem, unable to excrete acid. Then use K+ and urine pH to classify the RTA type. Also check clinical context: diarrhea is obvious clinically (stool history, volume status). RTA tends to be chronic and insidious. Rodriquez-Soriano, JASN 2002
Clinical Examples
📋 Case 1, Type 1 (Distal) RTA
Patient: 32F with Sjögren syndrome, fatigue, muscle weakness. BMP: K 2.8, HCO₃ 12, AG 10 (normal). Urine pH 6.2.
Diagnosis: Type 1 (Distal) RTA.
Key findings:
- Cannot acidify urine below 5.5, urine pH 6.2 confirms distal defect
- Hypokalemia (K 2.8), classic for Type 1
- Sjögren syndrome, autoimmune cause of Type 1 RTA
Treatment: NaHCO₃ 1–2 mEq/kg/day + KCl supplementation. Monitor for nephrocalcinosis.
📋 Case 2, Type 4 RTA
Patient: 65M with type 2 diabetes on lisinopril. BMP: K 6.1, HCO₃ 18, AG 10. Urine pH 5.0.
Diagnosis: Type 4 RTA.
Key findings:
- Hyperkalemia (K 6.1), hallmark of Type 4
- Diabetic nephropathy → hyporeninemic hypoaldosteronism
- ACEi (lisinopril) worsens by further reducing aldosterone
- Can acidify urine (pH 5.0), distinguishes from Type 1
Treatment: Stop lisinopril, low-K diet, fludrocortisone if persistent hyperkalemia.
📋 Case 3, Fanconi Syndrome (Type 2 RTA)
Patient: 8-year-old with failure to thrive, rickets, glycosuria with normal blood glucose, aminoaciduria.
Diagnosis: Fanconi syndrome → Type 2 (Proximal) RTA.
Key findings:
- Everything leaking through proximal tubule: glucose, amino acids, phosphate, bicarbonate, uric acid
- Glycosuria with normal serum glucose, pathognomonic for proximal tubular dysfunction
- Rickets, from phosphate wasting (hypophosphatemia)
- Failure to thrive, chronic acidosis impairs growth in children
Workup: Evaluate for underlying cause, in children, cystinosis is the most common cause. In adults, consider multiple myeloma (light chains), tenofovir, cisplatin.
⚡ Summary
Where RTA Sits
A non-anion-gap metabolic acidosis from defective renal acid handling, with the kidney rather than the gut losing the base. Calculate the urine anion gap to separate it from diarrhea: a negative gap means the kidney is excreting ammonium appropriately, so the loss is gastrointestinal; a positive gap means the kidney is not, which is RTA.
The Three Types in One Line Each
Type 1 (distal): cannot secrete hydrogen in the collecting duct. Type 2 (proximal): cannot reabsorb bicarbonate. Type 4: too little aldosterone effect, so both hydrogen and potassium secretion fall.
Potassium Sorts Them Fast
Types 1 and 2 are hypokalemic; type 4 is hyperkalemic. A non-gap acidosis with a high potassium is type 4 until proven otherwise, and that single observation does most of the work at the bedside.
Urine pH Separates 1 From 2
Type 1: urine pH stays above 5.5 even during acidemia, because the distal pump is broken and the urine cannot be acidified at all. Type 2: urine pH is below 5.5 once the serum bicarbonate falls below the reabsorptive threshold, since the distal mechanism works fine, and the bicarbonate simply stabilizes at a lower set point.
Type 4 Is the One You Will Actually See
It is by far the commonest RTA in practice, most often a diabetic with hyporeninemic hypoaldosteronism, usually on an ACE inhibitor or ARB. Also caused by potassium-sparing diuretics, NSAIDs, calcineurin inhibitors, TMP-SMX and heparin. Types 1 and 2 are tested more often than they are seen.
Match the Treatment to the Type
Type 1: modest bicarbonate or citrate (1 to 2 mEq/kg/day), which is usually enough because the deficit is fixed. Type 2: very large alkali doses (10 to 15 mEq/kg/day) plus a thiazide, because whatever is given is promptly wasted in the urine, and the thiazide induces mild volume contraction that enhances proximal reabsorption. Type 4: treat the hyperkalemia, stop the offending drug, and add fludrocortisone or a loop diuretic; alkali is rarely needed since correcting the potassium restores ammoniagenesis.
Replete Potassium Before the Bicarbonate
Giving bicarbonate shifts potassium into cells through hydrogen-potassium exchange, which deepens an existing hypokalemia and can cause arrhythmia or weakness. In types 1 and 2, replete or co-administer potassium, and use potassium citrate rather than sodium bicarbonate where hypokalemia is the problem.
Know the Complications and the Company They Keep
Type 1 causes nephrocalcinosis and calcium phosphate stones, because the persistently alkaline urine plus hypercalciuria and low urinary citrate is exactly the stone-forming recipe, and it also causes rickets or osteomalacia. Type 2 usually comes as part of Fanconi syndrome, with glycosuria at a normal serum glucose, phosphaturia, aminoaciduria and uricosuria, so look for multiple myeloma, tenofovir, ifosfamide and heavy metals. Type 1 is associated with Sjogren syndrome, lupus, amphotericin and lithium.
Related Topics
Acid-Base DisordersCalciphylaxis (Calcific Uremic Arteriolopathy)Chronic Kidney Disease (CKD)Contrast-Induced NephropathyDialysis IndicationsHypernatremia